Drug recall D-0024-2023
Product
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83
Reason for recall
Presence of Foreign Substance
Lots and codes
Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023
Recall details
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ
- Quantity
- N/A
- Distribution
- Nationwide with the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 18, 2022
- Terminated
- September 7, 2023
Related products
- Buprenorphine and Naloxone – drug information
- NDC 62756-969 Buprenorphine and Naloxone · Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride… · Sun Pharmaceutical Industries, Inc.
- NDC 62756-970 Buprenorphine and Naloxone · Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride… · Sun Pharmaceutical Industries, Inc.